References
- Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133:1270–1277.
- Poon E, Seed PT, Greaves MW, et al. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667–671.
- Choi WS, Lim ES, Ban GY, et al. Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria. Korean J Intern Med. 2018;33:185–192.
- Heng JK, Koh LJ, Toh MP, et al. A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore. Asia Pac Allergy. 2015;5:197–202.
- Taube KM. Patient-doctor relationship in dermatology: from compliance to concordance. Acta Derm Venereol. 2016;96:25–29.
- Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304–314.
- Sabate E. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003.
- Kaneko S, Masuda K, Hiragun T, et al. Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale-8. J Dermatol. 2015;42:1078–1082.
- Conlon NP, Edgar JD. Adherence to best practice guidelines in chronic spontaneous urticaria (CSU) improves patient outcome. Eur J Dermatol. 2014;24:385–386.
- Ferrer M, Jáuregui I, Bartra J, et al. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts. Br J Dermatol. 2009;160:823–827.
- Rimoldi M, Rossi O, Rota N. State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians’ and patients’ perspectives. BMJ Open. 2016;6:e012378.
- Senior V, Marteau TM, Weinman J, et al. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc Drugs Ther. 2004;18:475–481.
- Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27:1064–1073.
- Balbay O, Annakkaya AN, Arbak P, et al. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis. 2005;58:152–158.
- Okuno J, Yanagi H, Tomura S, et al. Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmacol. 1999;55:145–149.
- Jin J, Sklar GE, Min Sen Oh V, et al. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4:269–286.
- Apter AJ, Reisine ST, Affleck G, et al. Adherence with twice-daily dosing of inhaled steroids. Am J Respir Crit Care Med. 1998;157:1810–1817.
- Yavuz A, Tuncer M, Erdoğan O, et al. Is there any effect of compliance on clinical parameters of renal transplant recipients? Transplant Proc. 2004;36:120–121.
- Stilley CS, Sereika S, Muldoon MF, et al. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27:117–124.
- Wai CT, Wong ML, Ng S, et al. Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2005;21:1255–1262.